Literature DB >> 18313453

Altered expression of KIF17, a kinesin motor protein associated with NR2B trafficking, may mediate learning deficits in a Down syndrome mouse model.

Robin Roberson1, Laura Toso, Daniel Abebe, Catherine Y Spong.   

Abstract

OBJECTIVE: Down syndrome (DS), a major cause of mental retardation, affects 1 of 800 newborns. Mouse models for Down syndrome have been studied and found to have developmental and learning deficits, including the Ts65Dn (DS) mouse model. N-methyl-D-aspartate receptor NR2B subunit enhances synaptic plasticity. The up-regulation of KIF17, a motor protein that transports NR2B to the synaptic region parallels up-regulation of synaptic NR2B. Down regulation of KIF17 reflects up-regulation of less plastic NR2A subunit. We evaluated NR2B, NR2A, and KIF17 in Ts65Dn and control mice. STUDY
DESIGN: Ts65Dn (4) and control (4) adult brains were collected; NR2A, NR2B, and KIF17 were measured by Western blot and quantified using National Institutes of Health Image software. Comparisons were made using analysis of variance, < .05 was considered significant.
RESULTS: There was a significant decrease in KIF17 (P = .04) level in Ts65Dn mice as compared with the control animals, but there were no significant differences in the levels of NR2A (P = .79) and NR2B (P = .96).
CONCLUSION: The significant decrease of KIF17 inTs65Dn animals may in part mediate cognitive defects in DS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18313453      PMCID: PMC2274888          DOI: 10.1016/j.ajog.2008.01.033

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  21 in total

1.  Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport.

Authors:  M Setou; T Nakagawa; D H Seog; N Hirokawa
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

2.  KIF17 dynamics and regulation of NR2B trafficking in hippocampal neurons.

Authors:  Laurent Guillaud; Mitsutoshi Setou; Nobutaka Hirokawa
Journal:  J Neurosci       Date:  2003-01-01       Impact factor: 6.167

Review 3.  Down's syndrome.

Authors:  Nancy J Roizen; David Patterson
Journal:  Lancet       Date:  2003-04-12       Impact factor: 79.321

4.  Intellectual and adaptive functioning in individuals with Down syndrome in relation to age and environmental placement.

Authors:  F R Brown; M K Greer; E H Aylward; H H Hunt
Journal:  Pediatrics       Date:  1990-03       Impact factor: 7.124

5.  Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome.

Authors:  M T Davisson; C Schmidt; E C Akeson
Journal:  Prog Clin Biol Res       Date:  1990

Review 6.  The molecular basis of CaMKII function in synaptic and behavioural memory.

Authors:  J Lisman; H Schulman; H Cline
Journal:  Nat Rev Neurosci       Date:  2002-03       Impact factor: 34.870

Review 7.  Kinesin superfamily proteins and their various functions and dynamics.

Authors:  Nobutaka Hirokawa; Reiko Takemura
Journal:  Exp Cell Res       Date:  2004-11-15       Impact factor: 3.905

8.  Quantitative PCR genotyping assay for the Ts65Dn mouse model of Down syndrome.

Authors:  Dong P Liu; Cecilia Schmidt; Timothy Billings; Muriel T Davisson
Journal:  Biotechniques       Date:  2003-12       Impact factor: 1.993

9.  Phosphatidylinositol 3-kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms.

Authors:  Patricio Opazo; Ayako M Watabe; Seth G N Grant; Thomas J O'Dell
Journal:  J Neurosci       Date:  2003-05-01       Impact factor: 6.167

10.  Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test.

Authors:  Alberto C S Costa; Jonah J Scott-McKean; Melissa R Stasko
Journal:  Neuropsychopharmacology       Date:  2007-08-15       Impact factor: 7.853

View more
  10 in total

1.  The cyclic AMP response element-binding protein antisense oligonucleotide induced anti-nociception and decreased the expression of KIF17 in spinal cord after peripheral nerve injury in mice.

Authors:  Jinhua Bo; Wei Zhang; Xiaofeng Sun; Yan Yang; Xiaojie Liu; Ming Jiang; Zhengliang Ma; Xiaoping Gu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 2.  Prospects for improving brain function in individuals with Down syndrome.

Authors:  Alberto C S Costa; Jonah J Scott-McKean
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

3.  Proteomic analysis of six- and twelve-month hippocampus and cerebellum in a murine Down syndrome model.

Authors:  Guido N Vacano; David S Gibson; Abdullah Arif Turjoman; Jeremy W Gawryluk; Jonathan D Geiger; Mark Duncan; David Patterson
Journal:  Neurobiol Aging       Date:  2017-11-26       Impact factor: 4.673

4.  Exaggerated NMDA mediated LTD in a mouse model of Down syndrome and pharmacological rescuing by memantine.

Authors:  Jonah J Scott-McKean; Alberto C S Costa
Journal:  Learn Mem       Date:  2011-11-18       Impact factor: 2.460

5.  Systems genetics identifies Hp1bp3 as a novel modulator of cognitive aging.

Authors:  Sarah M Neuner; Benjamin P Garfinkel; Lynda A Wilmott; Bogna M Ignatowska-Jankowska; Ami Citri; Joseph Orly; Lu Lu; Rupert W Overall; Megan K Mulligan; Gerd Kempermann; Robert W Williams; Kristen M S O'Connell; Catherine C Kaczorowski
Journal:  Neurobiol Aging       Date:  2016-06-17       Impact factor: 4.673

6.  The kinesin superfamily protein KIF17: one protein with many functions.

Authors:  Margaret T T Wong-Riley; Joseph C Besharse
Journal:  Biomol Concepts       Date:  2012-06-01

7.  Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK-801.

Authors:  A Siddiqui; T Lacroix; M R Stasko; J J Scott-McKean; A C S Costa; K J Gardiner
Journal:  Genes Brain Behav       Date:  2008-10       Impact factor: 3.449

8.  Biallelic Variants in KIF17 Associated with Microphthalmia and Coloboma Spectrum.

Authors:  Antonella Riva; Antonella Gambadauro; Valeria Dipasquale; Celeste Casto; Maria Domenica Ceravolo; Andrea Accogli; Marcello Scala; Giorgia Ceravolo; Michele Iacomino; Federico Zara; Pasquale Striano; Caterina Cuppari; Gabriella Di Rosa; Maria Concetta Cutrupi; Vincenzo Salpietro; Roberto Chimenz
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

9.  Tc1 mouse model of trisomy-21 dissociates properties of short- and long-term recognition memory.

Authors:  Jessica H Hall; Frances K Wiseman; Elizabeth M C Fisher; Victor L J Tybulewicz; John L Harwood; Mark A Good
Journal:  Neurobiol Learn Mem       Date:  2016-02-08       Impact factor: 2.877

Review 10.  Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics.

Authors:  Nicole Créau
Journal:  Neural Plast       Date:  2012-07-12       Impact factor: 3.599

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.